Two Sigma Advisers’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,866
Closed -$1.4M 2499
2024
Q3
$1.4M Sell
30,866
-15,156
-33% -$687K ﹤0.01% 1256
2024
Q2
$1.79M Sell
46,022
-5,969
-11% -$232K ﹤0.01% 1246
2024
Q1
$1.68M Sell
51,991
-13,800
-21% -$445K ﹤0.01% 1315
2023
Q4
$1.89M Buy
65,791
+12,691
+24% +$364K ﹤0.01% 1313
2023
Q3
$1.47M Sell
53,100
-22,700
-30% -$628K ﹤0.01% 1354
2023
Q2
$2.03M Sell
75,800
-99,900
-57% -$2.67M 0.01% 1195
2023
Q1
$3.81M Sell
175,700
-3,900
-2% -$84.5K 0.01% 944
2022
Q4
$4.28M Sell
179,600
-10,700
-6% -$255K 0.01% 848
2022
Q3
$3.75M Buy
190,300
+83,100
+78% +$1.64M 0.01% 876
2022
Q2
$2.09M Sell
107,200
-22,800
-18% -$444K 0.01% 1191
2022
Q1
$3.32M Buy
130,000
+44,500
+52% +$1.14M 0.01% 994
2021
Q4
$2.15M Buy
85,500
+19,600
+30% +$493K 0.01% 1153
2021
Q3
$1.81M Buy
65,900
+56,200
+579% +$1.55M ﹤0.01% 1309
2021
Q2
$308K Buy
9,700
+5,000
+106% +$159K ﹤0.01% 2133
2021
Q1
$216K Buy
+4,700
New +$216K ﹤0.01% 2338